Joint count reliability in psoriatic arthritis observational trials-an unreported problem

Rheumatology (United Kingdom)

Volumn 51, Issue 7, 2012, Pages 1333-1334

  Tillett, William ^a   Shaddick, Gavin ^b   Korendowych, Eleanor ^a   de Vries, Corinne S ^c   McHugh, Neil ^a,c  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b University of Bath   (United Kingdom)

^c University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL NURSE SPECIALIST; CORRELATION COEFFICIENT; DISEASE ACTIVITY; DISEASE DURATION; EXPERIENCE; HUMAN; INTERRATER RELIABILITY; JOINT SWELLING; LATIN SQUARE DESIGN; LETTER; OBSERVATIONAL STUDY; OCCUPATIONAL THERAPIST; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; WORK DISABILITY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; JOINTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84863822901     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes095     Document Type: Letter

References (10)

1. Krippendorff K. Content analysis: an introduction to its methodology, 2nd edn. London: Sage, 2004: xiii.
2. Chandran V, Gottlieb A, Cook RJ et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum 2009;61:1235-42.
3. Gladman DD, Cook RJ, Schentag C et al. The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 2004;31: 1126-31.
4. Gladman DD, Farewell V, Buskila D et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990;17:62-4.
5. Gladman DD, Inman RD, Cook RJ et al. International spondyloarthritis interobserver reliability exercise-the INSPIRE study: I. Assessment of spinal measures. J Rheumatol 2007;34:1733-9.
6. Saad AA, Ashcroft DM, Watson KD et al. Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register. Rheumatology 2010;49: 697-705.
7. Scarpa R, Atteno M, Lubrano E et al. The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol 2011;30: 1063-7.
8. Yang Q, Qu L, Tian H et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2011;25: 1409-14.
9. Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmstrom G, Larsson PT. The Swedish early psoriatic arthritis register-2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008;35: 668-73.
10. Kristensen LE, Gulfe A, Saxne T, Geborek P. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register. Ann Rheum Dis 2008; 67:364-9.